Shichiri M, Kishikawa H, Sakakida M, Kajiwara K, Hashiguchi Y, Nishida K, Uemura T, Konno Y, Ichinose K
Department of Metabolic Medicine, Kumamoto University Medical School, Japan.
Diabetes Res Clin Pract. 1994 Oct;24 Suppl:S251-9. doi: 10.1016/0168-8227(94)90258-5.
The artificial endocrine pancreas is a feedback control system regulating insulin delivery on a minute-by-minute basis according to the measured blood glucose levels. The bedside-type artificial endocrine pancreas has been proven to be useful not only as a therapeutic tool for diabetes mellitus but also as an elegant research tool for investigating the pathophysiology of the disease. With significant advances in the development of a subcutaneous tissue glucose monitoring system, the wearable-type artificial endocrine pancreas has been applied to diabetic patients. With this system, perfect glycemic control can be obtained for longer periods in ambulatory diabetic patients. The trend in the development of the artificial endocrine pancreas is now directed to implantable devices. Much efforts have been conducted to realize these devices.
人工内分泌胰腺是一种反馈控制系统,可根据测得的血糖水平每分钟调节胰岛素的输送量。床边型人工内分泌胰腺已被证明不仅是糖尿病的治疗工具,也是研究该疾病病理生理学的理想研究工具。随着皮下组织葡萄糖监测系统的重大进展,可穿戴型人工内分泌胰腺已应用于糖尿病患者。使用该系统,可以使门诊糖尿病患者在更长的时间内实现完美的血糖控制。人工内分泌胰腺的发展趋势现在指向可植入设备。为实现这些设备已经付出了很多努力。